Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000071

EVP, Chf Clinical Develop Ofcr sold 9,302 shares at $75.59 ($703,138)

  • EVP, Chf Clinical Develop Ofcr acquired 21,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-15 Exercise or conversion : show line 1 in the form +21,685 73,192 D
2026-01-16 Sale : show line 2 in the form −9,302 $75.59 $703,138 63,890 D
Open-market sales · 9,302 sh · avg $75.59 · $703,138

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-01-15 Grant or award : show line 3 in the form Performance Restricted Stock Units +25,800 91,237 D
2026-01-15 Exercise or conversion : show line 4 in the form Restricted Stock Unit −21,685 39,251 D
2026-01-15 Grant or award : show line 5 in the form Restricted Stock Unit +9,675 48,926 D
Loading xslF345X05/edgardoc.xml…